July 20, 2010
Posted by admin
Embryonic Stem Cell-Based Treatments and Cures: Closer Than You Think
Parkinson’s Disease. Macular Degeneration. Alzheimer’s Disease. Heart Disease.
What do all these diseases and conditions have in common? All are chronic, debilitating conditions for which modern medicine has fallen short in terms of providing truly effective treatments, let alone cures.
Many scientists agree that only the field of embryonic stem cell research truly has the potential to develop cures for these and other conditions in coming years. Advanced Cell Technology (ACT) is at the forefront of these efforts.
One major hindrance to advancement in this promising field of research has been the ethical concerns expressed in certain quarters, revolving around the ways in which embryonic stem cells are derived. Fortunately, ACT has come up with a bridge between the two sides in this seemingly intractable ethical debate.
ACT has created a new method for deriving embryonic stem cells without doing any damage to the embryo. Called the “Single-Cell Blastomere” (SCB) technique, it is a method for deriving these “master” cells without affecting the developmental potential of the embryo. First described by ACT scientists in a major paper in the scientific journal Nature, this proprietary technique mitigates the major ethical concerns heretofore surrounding the sector.
Using its proprietary SCB technology, ACT has developed a treatment for eye disease, specifically a form of Macular Degeneration called Stargardt’s Macular Dystrophy (SMD, also known as Stargardt Disease), a form of juvenile macular degeneration that causes progressive vision loss, eventually resulting in blindness.
In studies designed to satisfy the US Food and Drug Administration (FDA), this treatment has already been tested on animals and has demonstrated an excellent safety profile. FDA approval for a “Phase I/II” clinical trial is anticipated later this year. Twelve patients are to be enrolled into the study, at three clinical sites throughout the country.
This would mark a historic milestone: the first-ever FDA-approved human clinical trial using embryonic stem cells. After years of anticipation, it would mark the arrival of embryonic stem cell research into the clinic.
ACT believes this initial program will help validate human embryonic stem cell research as a viable path towards true cures for a variety of debilitating diseases and conditions, including those listed at the beginning of this blog post. After success with this program, the “flood gates” might well open.
With this background in mind, we at ACT pose the following questions, to patients, patient advocates and other interested parties:
- Do you know anyone with Macular Degeneration or Stargardt’s Disease?
- What is your view on using stem cells to treat disease?
- Have you heard before of ACT’s “embryo-safe” technology? What are your impressions?
- Does the growing government support for stem cell research change your attitude toward it?
You may remain completely anonymous in your post, feel free to post responses here using the comment button below or Join us on facebook and share your strength and hope.
Embryonic Stem Cell-Based Treatments and Cures: Closer Than You Think
21 Comments
July 23, 2010
1. Do you know anyone with Macular Degeneration or Stargardt’s Disease? – Yes I have Stargardt’s.
2. What is your view on using stem cells to treat disease? – Using your SCB method me a propnent for Stem cell treatments. I believe Stem cell treatments will be the only effective treatments for Stargardt’s.
3. Have you heard before of ACT’s “embryo-safe” technology? What are your impressions? – Yes! I think it is absolutely inspired.
4. Does the growing government support for stem cell research change your attitude toward it? – No, the change in method changes my attitude towards Stem cells. My only question is; how does one become one of the lucky 12 patients in the clinical trial?
July 23, 2010
(re-submitted with corrections)
I know someone who has Macular Degeneration and someone who has Stargardt’s Disease. I have seen how these diseases negatively affect one’ quality of life. I look forward to the day when stem cells are used to treat these and other diseases. In fact, as a stroke victim myself, I am hopeful that stem cell treatments will soon be available to help me overcome the disabilities caused by the stroke. I am aware of ACT’s before of ACT’s “embryo-safe” technology and think this is a wonderful development. I believe that most people still associate emryonic stem cell research and therapy potential with the destruction of the embryo.
July 27, 2010
found your site on del.icio.us today and really liked it.. i bookmarked it and will be back to check it out some more later
July 28, 2010
1. Yes, I was just diagnosed with an adult form of Stargardt’s, known as fundus flavimaculatus at the age of 58 (nothing juvenile about that!). My vision is quite good at the moment. I was most disappointed in that I’m no longer a candidate for cataract surgery.
2. I’m all in favor of using stem cells to treat disease.
3. I was not aware of ACT’s embryo-safe technology, but I had no ethical issues with stem cell research.
4. I thought the previous generation of politicians was foolish to ban stem cell research. I definitely want to be kept up-to-date on the progress of the clinical trials. I know that my eyesight won’t improve, but would love for it not to get any worse. At least I’m told that it is slow progressing so I have time for the cure!
July 29, 2010
it was very interesting to read http://www.advancedcellpatients.com
I want to quote your post in my blog. It can?
And you et an account on Twitter?
July 30, 2010
I just read an article on Lifenews.com that said Geron was just granted approval by the FDA to begin Human clinical trials using ES cells. ACT appears to claim the same thing or am I missing something?
July 31, 2010
While I don’t know anyone with Stargardt’s, my 13-year-old daughter has panuveitis, which has resulted in complete vision loss in one eye. We are very hopeful that stem cell research will restore her vision some day. I just happened to see an article about the FDA’s recent approval for ACT’s trial, and then came to this site. After reading the article and checking out the ACT website, I’m inspired by the company’s work and hopeful that they will consider a trial for those with uveitis, too.
August 1, 2010
Kate, thank you for your input. Please feel free to join us on our linkedIN group: http://www.linkedin.com/groups?mostPopular=&gid=3260687 and start a topic about uveitis.
August 2, 2010
Jim, this is true and we are excited! However, ACT is working on eye disease and Geron is working on the spine, we cover this topic here: http://www.advancedcellpatients.com/2010-08-hopes-confirmed-with-science-geron-tackles-spinal-injury-act-congratulates.html
August 2, 2010
Yes, you can quote our blog, also, we offer RSS feeds. Here is our twitter account: https://twitter.com/ACTCbiotech
August 3, 2010
Good post and this fill someone in on helped me alot in my college assignement. Gratefulness you as your information.
August 6, 2010
very good information you write it very clean. I’m very lucky to get this information from
you.
August 6, 2010
Both I and my brother have Stargardt’s. I began to lose my vision at 18 and at 47 have had no central vision for over 25 years but maintain peripheral. My brother, a couple of years younger, is about the same.
He has followed developments through this site for many months. This is my first visit. We are looking forward to the start of the clinical trials.
What would the Company’s view be to the basic question of how long is there to wait before treatment becomes available to such as us in the UK? In our forties, time is not on our side as to go out and have a knock up on a tennis court is still something we would love to do. Should we be hopeful or realistic?
August 10, 2010
I will use your advice from now on. Jaap
August 10, 2010
wow.. i’m very
enjoy reading your post. great.
August 24, 2010
My 81 year old mother has Macular Degeneration. She has managed to live alone up until now, but it’s getting more difficult due to severe vision loss. She can’t drive; has difficulty doing the simplest daily tasks.
Is it realistic to hope that there may be a trial or, better still, a cure in her lifetime?
What can I do to support stem cell research in light of recent federal judicial decision?
September 11, 2010
I know somebody with retinopathy of prematurity (ROP). With retinal detachments in both eyes. If these clinical trials seem to be the answer for Macular Degeneration, is there a probability that it can be beneficial for someone with ROP as well? I believe stem cell research is one of the greatest discoveries ever. It well could be the answer to many things. I think ACT’s “embryo safe technology”, is an excellent way to go about doing cell reasearch. I’m so excited of what the future could hold for us with this research. I will keep posted.
September 26, 2010
I have to hear exactly what Debora can do about that
Beau
September 26, 2010
I’ve been a fan of this blog for a long time, keep it up.
September 26, 2010
How long have you been carrying this out?
September 27, 2010
Great writing! Maybe you could do a follow up to this topic!!!
Jon
Leave a comment